D. Azria

13.1k total citations · 1 hit paper
372 papers, 7.6k citations indexed

About

D. Azria is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, D. Azria has authored 372 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Oncology, 153 papers in Pulmonary and Respiratory Medicine and 108 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in D. Azria's work include Advanced Radiotherapy Techniques (93 papers), Breast Cancer Treatment Studies (76 papers) and Prostate Cancer Treatment and Research (46 papers). D. Azria is often cited by papers focused on Advanced Radiotherapy Techniques (93 papers), Breast Cancer Treatment Studies (76 papers) and Prostate Cancer Treatment and Research (46 papers). D. Azria collaborates with scholars based in France, Switzerland and United States. D. Azria's co-authors include Mahmut Özsahin, André Pèlegrin, P. Fenoglietto, C. Lemanski, Abderrahim Zouhair, Jean‐Bernard Dubois, N. Aillères, Yazid Belkacémi, Sophie Gourgou and Christophe Hennequin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

D. Azria

342 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2

2010 537 citations D. Azria et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Azria France	46	3.4k	2.8k	2.3k	2.0k	1.7k	372	7.6k
Bin S. Teh United States	48	2.0k 0.6×	4.0k 1.4×	2.0k 0.8×	1.6k 0.8×	1.1k 0.6×	374	8.4k
Umberto Ricardi Italy	48	2.7k 0.8×	4.8k 1.7×	2.3k 1.0×	2.4k 1.2×	906 0.5×	362	10.0k
Lorenzo Livi Italy	36	1.7k 0.5×	2.6k 0.9×	1.2k 0.5×	1.5k 0.8×	1.7k 1.0×	391	6.0k
Richard Fisher Australia	37	2.5k 0.7×	1.8k 0.6×	2.0k 0.9×	1.4k 0.7×	1.1k 0.7×	112	6.2k
Wim L.J. van Putten Netherlands	56	2.6k 0.8×	2.8k 1.0×	1.5k 0.7×	1.0k 0.5×	1.2k 0.7×	155	10.5k
Christopher U. Jones United States	28	3.7k 1.1×	5.2k 1.8×	3.3k 1.4×	1.2k 0.6×	802 0.5×	68	10.3k
Mary F. Mulcahy United States	58	4.0k 1.2×	3.2k 1.1×	3.1k 1.3×	1.9k 1.0×	1.5k 0.9×	220	11.7k
Alan Horwich United Kingdom	45	2.6k 0.8×	5.6k 2.0×	2.4k 1.1×	1.5k 0.8×	1.5k 0.9×	140	10.4k
Carien L. Creutzberg Netherlands	61	2.9k 0.9×	1.7k 0.6×	2.3k 1.0×	1.3k 0.7×	1.9k 1.1×	208	15.5k
Patricia J. Eifel United States	59	2.7k 0.8×	1.9k 0.7×	4.7k 2.0×	1.7k 0.8×	982 0.6×	263	13.3k

Countries citing papers authored by D. Azria

Since Specialization

Citations

This map shows the geographic impact of D. Azria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Azria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Azria more than expected).

Fields of papers citing papers by D. Azria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Azria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Azria. The network helps show where D. Azria may publish in the future.

Co-authorship network of co-authors of D. Azria

This figure shows the co-authorship network connecting the top 25 collaborators of D. Azria. A scholar is included among the top collaborators of D. Azria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Azria. D. Azria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Belkacémi, Yazid, D. Lerouge, C. Durdux, et al.. (2023). Revue de morbidité et mortalité en radiothérapie : procédure, implémentation et perspectives du projet national français « Proust ». Cancer/Radiothérapie. 27(6-7). 474–479.

Riou, O., et al.. (2023). Acceptance, commissioning and quality assurance of the MRIdian®: Site experience and three years follow-up. Cancer/Radiothérapie. 27(4). 303–311. 2 indexed citations

Bourbonne, Vincent, et al.. (2023). Phase de consolidation (docteur junior) en oncologie–radiothérapie en France : état des lieux et perspectives. Cancer/Radiothérapie. 27(8). 718–724.

Azria, D., et al.. (2023). Robustness of Breast Margins with Volumetric Modulated Arc Therapy without a Six-Degrees-of-Freedom Couch: A Dosimetric Evaluation. Journal of Clinical Medicine. 12(3). 862–862. 1 indexed citations

Touraine, Célia, Audrey Winter, Florence Castan, D. Azria, & Sophie Gourgou. (2023). Time-Dependent ROC Curve Analysis for Assessing the Capability of Radiation-Induced CD8 T-Lymphocyte Apoptosis to Predict Late Toxicities after Adjuvant Radiotherapy of Breast Cancer Patients. Cancers. 15(19). 4676–4676. 2 indexed citations

Castan, Florence, Eric Assénat, Boris Guiu, et al.. (2021). Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma. Cancers. 13(19). 4853–4853. 5 indexed citations

Hutin, Mathilde, Brigitte Trétarre, Carla Gras, et al.. (2020). Le cancer du rein dans le département de L’Hérault : résultats de 30 ans d’enregistrement. Progrès en Urologie. 31(3). 175–182. 1 indexed citations

Spano, Jean‐Philippe, D. Azria, & Anthony Gonçalvès. (2015). Patients’ satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy. Critical Reviews in Oncology/Hematology. 94(3). 270–278. 4 indexed citations

Métellus, Philippe, Agnès Tallet, F. Dhermain, et al.. (2015). Stratégie globale de prise en charge des métastases cérébrales : une approche multidisciplinaire. Cancer/Radiothérapie. 19(1). 61–65. 4 indexed citations

10.

Théry, Jean‐Christophe, Jean‐Philippe Spano, D. Azria, Éric Raymond, & F. Penault Llorca. (2014). Resistance to human epidermal growth factor receptor type 2-targeted therapies. European Journal of Cancer. 50(5). 892–901. 45 indexed citations

11.

Azria, D., et al.. (2013). Prognostic factors of brain metastases from breast cancer: Impact of targeted therapies. The Breast. 22(5). 993–998. 23 indexed citations

12.

Riou, O., P. Fenoglietto, C. Lemanski, & D. Azria. (2012). Radiothérapie conformationnelle avec modulation d’intensité dans les cancers du sein : intérêt, limitations, modalités techniques. Cancer/Radiothérapie. 16(5-6). 479–484. 9 indexed citations

13.

Assénat, Eric, Simon Thézenas, Nicolas Flori, et al.. (2011). Prophylactic Percutaneous Endoscopic Gastrostomy in Patients With Advanced Head and Neck Tumors Treated by Combined Chemoradiotherapy. Journal of Pain and Symptom Management. 42(4). 548–556. 41 indexed citations

14.

Lacombe, Jérôme, et al.. (2011). Intérêt des marqueurs sanguins dans la prédiction de la toxicité radio-induite. Cancer/Radiothérapie. 15(5). 390–393. 1 indexed citations

15.

Özsahin, Mahmut, Guenther Gruber, Ömür Karakoyun-Çelik, et al.. (2010). Outcome and Prognostic Factors in Olfactory Neuroblastoma: A Rare Cancer Network Study. International Journal of Radiation Oncology*Biology*Physics. 78(4). 992–997. 74 indexed citations

16.

Zouhair, A., Oscar Matzinger, D. Azria, et al.. (2010). Chimioradiothérapie postopératoire des cancers des voies aérodigestives : vers un nouveau standard ?. Cancer/Radiothérapie. 14(3). 217–221. 1 indexed citations

17.

Belkacémi, Yazid, Joseph Gligorov, Mahmut Özsahin, et al.. (2008). Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study. Annals of Oncology. 19(6). 1110–1116. 87 indexed citations

18.

Assénat, Eric, Frédéric Bibeau, D. Azria, et al.. (2007). The value of endoscopic rectal ultrasound in predicting the lateral clearance and outcome in patients with lower-third rectal adenocarcinoma. Endoscopy. 39(4). 309–313. 21 indexed citations

19.

Ho, Alice Y., David P. Atencio, Sheila Annie Peters, et al.. (2006). Genetic Predictors of Adverse Radiotherapy Effects: The Gene-PARE project. International Journal of Radiation Oncology*Biology*Physics. 65(3). 646–655. 78 indexed citations

20.

Lemanski, C., D. Azria, Simon Thézenas, et al.. (2006). Intraoperative radiotherapy given as a boost for early breast cancer: Long-term clinical and cosmetic results. International Journal of Radiation Oncology*Biology*Physics. 64(5). 1410–1415. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact